Icodextrin Patent Expiration

Icodextrin is Used for treating kidney failure by removing waste and extra fluid through the peritoneal membrane. It was first introduced by Baxter Healthcare Corp in its drug Extraneal on Dec 20, 2002.


Icodextrin Patents

Given below is the list of patents protecting Icodextrin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Extraneal US6248726 Method of peritoneal dialysis using glucose polymer solutions Jun 19, 2018

(Expired)

Baxter Hlthcare
Extraneal US6077836 Peritoneal dialysis and compositions for use therein Jun 20, 2017

(Expired)

Baxter Hlthcare



Icodextrin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List